397 related articles for article (PubMed ID: 15830093)
1. Hyperhomocysteinemia and atherosclerosis.
Yang F; Tan HM; Wang H
Sheng Li Xue Bao; 2005 Apr; 57(2):103-14. PubMed ID: 15830093
[TBL] [Abstract][Full Text] [Related]
2. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
Jakubowski H
J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978
[TBL] [Abstract][Full Text] [Related]
3. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease.
Austin RC; Lentz SR; Werstuck GH
Cell Death Differ; 2004 Jul; 11 Suppl 1():S56-64. PubMed ID: 15243582
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine, coagulation, platelet function, and thrombosis.
Coppola A; Davi G; De Stefano V; Mancini FP; Cerbone AM; Di Minno G
Semin Thromb Hemost; 2000; 26(3):243-54. PubMed ID: 11011842
[TBL] [Abstract][Full Text] [Related]
5. [Hyperhomocysteinemia: atherothrombosis and neurotoxicity].
Fridman O
Acta Physiol Pharmacol Ther Latinoam; 1999; 49(1):21-30. PubMed ID: 10797837
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocysteinemia: an additional cardiovascular risk factor.
Fanapour PC; Yug B; Kochar MS
WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
[TBL] [Abstract][Full Text] [Related]
7. [Review of the role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric disorders--current evidence and preliminary recommendations].
Herrmann W; Lorenzl S; Obeid R
Fortschr Neurol Psychiatr; 2007 Sep; 75(9):515-27. PubMed ID: 17729191
[TBL] [Abstract][Full Text] [Related]
8. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine impaired endothelial function through compromised vascular endothelial growth factor/Akt/endothelial nitric oxide synthase signalling.
Yan TT; Li Q; Zhang XH; Wu WK; Sun J; Li L; Zhang Q; Tan HM
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1071-7. PubMed ID: 20698860
[TBL] [Abstract][Full Text] [Related]
10. Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy.
Yap S; Naughten ER; Wilcken B; Wilcken DE; Boers GH
Semin Thromb Hemost; 2000; 26(3):335-40. PubMed ID: 11011851
[TBL] [Abstract][Full Text] [Related]
11. Mutations in methylenetetrahydrofolate reductase or cystathionine beta-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice.
Chwatko G; Boers GH; Strauss KA; Shih DM; Jakubowski H
FASEB J; 2007 Jun; 21(8):1707-13. PubMed ID: 17327360
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
[TBL] [Abstract][Full Text] [Related]
13. Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms.
Zhou J; Austin RC
Biofactors; 2009; 35(2):120-9. PubMed ID: 19449439
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia.
He L; Zeng H; Li F; Feng J; Liu S; Liu J; Yu J; Mao J; Hong T; Chen AF; Wang X; Wang G
Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E1061-5. PubMed ID: 20858749
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics of hyperhomocysteinemia in dialysis patients].
Lovcić V; Kes P; Reiner Z
Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine and Hyperhomocysteinaemia.
Zaric BL; Obradovic M; Bajic V; Haidara MA; Jovanovic M; Isenovic ER
Curr Med Chem; 2019; 26(16):2948-2961. PubMed ID: 29532755
[TBL] [Abstract][Full Text] [Related]
17. Hyperhomocysteinemia and hyperglycemia induce and potentiate endothelial dysfunction via μ-calpain activation.
Cheng Z; Jiang X; Pansuria M; Fang P; Mai J; Mallilankaraman K; Gandhirajan RK; Eguchi S; Scalia R; Madesh M; Yang X; Wang H
Diabetes; 2015 Mar; 64(3):947-59. PubMed ID: 25352635
[TBL] [Abstract][Full Text] [Related]
18. Hyperhomocysteinemia: a biochemical link between bone and cardiovascular system diseases?
Petramala L; Acca M; Francucci CM; D'Erasmo E
J Endocrinol Invest; 2009; 32(4 Suppl):10-4. PubMed ID: 19724160
[TBL] [Abstract][Full Text] [Related]
19. N-Homocysteinylation impairs collagen cross-linking in cystathionine β-synthase-deficient mice: a novel mechanism of connective tissue abnormalities.
Perła-Kajan J; Utyro O; Rusek M; Malinowska A; Sitkiewicz E; Jakubowski H
FASEB J; 2016 Nov; 30(11):3810-3821. PubMed ID: 27530978
[TBL] [Abstract][Full Text] [Related]
20. Role of redox factor-1 in hyperhomocysteinemia-accelerated atherosclerosis.
Dai J; Li W; Chang L; Zhang Z; Tang C; Wang N; Zhu Y; Wang X
Free Radic Biol Med; 2006 Nov; 41(10):1566-77. PubMed ID: 17045925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
